Company intelligence / Profile preview

NanoHelix

Daejeon, Daejeon Metropolitan City, South Koreananohelix.net ↗

Ownership: Private
Development stage: Commercial

Overview

NanoHelix develops and manufactures a wide range of high-quality enzymes and molecular biology reagents for use in molecular diagnostics. The company has extensive production capabilities for key enzymes such as Taq DNA polymerase, reverse transcriptases, RNase inhibitors, and diagnostic kits. Their proprietary technologies support custom development projects for clients globally. They operate under ISO13485-certified quality management with GMP facilities.

Modalities: Protein (enzymes)Recombinant protein (e.g., Taq polymerase, RNase inhibitor)Diagnostic kit (PCR MDx Kit)Small molecule (for some reagents and buffers)DNA/RNA purification systems
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on NanoHelix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoHelix.

Explore the full profile